This month we revisit the dramatic rise in the use of weight loss injectables and the important role of pathology and nutritional testing for managing controlled weight loss.
The rapid rise in popularity brings significant health risks, emphasising the need for UK clinical teams to adopt comprehensive pre-treatment and
follow-up protocols to ensure patient safety. This article explores the risks of weight loss injections and the role of pathology and nutritional testing in mitigating these risks.
Understanding Weight Loss Injections
Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide and liraglutide, act by mimicking the body’s natural GLP-1 hormone. This hormone slows gastric emptying, reduces appetite, and enhances insulin secretion, leading to weight loss.
While these injections can benefit patients struggling with weight management, they are not without risks.
Unintended side effects and potential nutritional deficiencies are emerging as significant concerns, particularly when prescriptions are made without comprehensive patient assessment or follow-up.
Key Health Risks Associated with Weight Loss Injections
Gastrointestinal Disturbances
GLP-1 agonists can cause nausea, vomiting, diarrhoea, and constipation, particularly in the initial stages. These effects, though typically transient, can impair nutrient
absorption and discourage eating, further elevating the risk of malnutrition.
Nutrient Deficiencies
Appetite suppression can inadvertently lead to insufficient nutrient intake. Common deficiencies include vitamin B12, vitamin D, iron and zinc, which are critical to metabolic function, immunity, and overall health. Prolonged deficiency in these nutrients can exacerbate issues such as fatigue and cognitive issues.
Impact on Pancreatic and Thyroid Health
There are serious, though rare, risks associated with GLP-1 agonists. Cases of acute pancreatitis and, in some studies, an association with thyroid tumours have been noted. Pancreatitis risk is particularly elevated in patients with a history of pancreatic or gallbladder issues, and it is critical that these factors are considered before initiating treatment.
The Role of Pathology and Nutritional Tests
Adopting a proactive approach through pathology and nutritional testing can help identify patients who may be at higher risk of adverse effects from weight loss injections, enabling safer and more personalised treatment plans.
Baseline Pathology Testing
Conducting baseline pathology tests prior to administering weight loss injections provides critical insights into patient suitability.
Ongoing Monitoring
Regular follow-up testing, particularly in the first months of treatment, allows early detection of potential complications.
Nutritional Testing
Regular nutritional testing for vitamins (B12, D) and minerals (iron, zinc and red cell magnesium) is highly recommended, as nutrient deficiencies can worsen due to reduced appetite.
Personalised Nutrition Plans
Developing personalised dietary strategies or referring patients to a nutritionist can help mitigate nutritional deficiencies.
Encouraging Lifestyle Changes
Weight loss injections can be most effective when combined with sustainable lifestyle modifications. Regular physical activity and behavioural support not only improve patient outcomes but also foster habits that may enhance long-term adherence to a healthier lifestyle.
To support your weight loss programs VHL offers two baseline profiles (postal and collection) and an ongoing monitoring profile.
Ethical and Practical Considerations
With the rapid adoption of weight loss injections, it’s crucial to remember the ethical obligations surrounding their prescription. Doctors have a duty to fully inform patients of potential side effects and to ensure the treatment aligns with the patient’s health needs.
Beyond the direct health risks, weight loss injections can potentially foster unrealistic expectations among patients, who may perceive these treatments as standalone solutions. Reinforcing the importance of a holistic, lifestyle-based approach can foster better long-term health and mitigate the potential for dependency on pharmacologic solutions alone.
Conclusion
While weight loss injections offer a promising option for weight management, they come with risks that must be carefully managed. Pathology and nutritional testing can play a role in personalising treatment plans, and monitoring for adverse effects.
Combining pharmacologic treatment with dietary support and lifestyle modifications can enhance the benefits of weight loss injections while minimising risks.
By approaching these treatments holistically, doctors can help patients achieve safer and more sustainable health and weight loss outcomes.